Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Elise R. A. Pennings(Amsterdam Neuroscience), Emma Morris(University College London Hospitals NHS Foundation Trust), Yolanda Cabrerizo(European Hematology Association), Solène Clavreul(European Federation of Allergy and Airways Diseases Patients Associations), Sébastien Anguille(Antwerp University Hospital), Marie Robin(Universität Hamburg), Julio Delgado(Departament de Salut), Hélène Trebeden‐Negre(Institut de Relations Internationales et Stratégiques), Anne M. Spanjaart(Amsterdam University Medical Centers), Simone Oerlemans(Netherlands Comprehensive Cancer Organisation), R. D. Liu(Amsterdam Neuroscience), Andreas Kremer(Erasmus MC), Myriam Pannard(Inserm), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Olga Millán(RUAG (Germany)), Ulrich Jäger(Medical University of Vienna), Carin A. Uyl‐de Groot(Erasmus University Rotterdam), Birgit I. Lissenberg‐Witte(OLVG), Samantha Nier(Advocates for Youth), Natacha Bolaños(HOPE Clinic), Maik Luu(Klinik und Poliklinik für Psychosomatik und Psychotherapie), Carmen Sanges(Augenklinik Universitätsklinikum Würzburg), Delphine Maucort‐Boulch(Université Claude Bernard Lyon 1), Geertruida H. de Bock(University Medical Center Groningen), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Frederick W. Thielen(University Medical Center Freiburg), Eglys González‐Marcano(RUAG (Germany)), Marie Préau(Inserm), Scott Wagers(Erasmus Hospital), Michael Hudecek(Lighthouse Guild), Pacôme Lecot(Institut National du Cancer), Margot Lorrain(University of Luxembourg), Caroline Dreuillet(Institut National du Cancer), Barbara Huber(Augenklinik Universitätsklinikum Würzburg), Anna Fleischer(Universitätsklinikum Würzburg), Lutgart Roux-Opstaele(Institut National du Cancer)
Cited by 3
Related Papers
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
|Nature Communications|2021|669